Concepedia

Riccardo Giossi

RG

4

Publications

631

Citations

4

H-Index

2021

Active since

Affiliations

Fondazione IRCCS Istituto Neurologico Carlo Besta(Current)

University of Milan

University of Belgrade

Riccardo Giossi is an author at Fondazione IRCCS Istituto Neurologico Carlo Besta specializing in medicine, patient safety, and clinical trials.

ORCID

Top concepts

Publications per year

2021–2024

4

Publications

4

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

,

Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study

Licia Grazzi, Riccardo Giossi, Danilo Antonio Montisano et al. · The Journal of Headache and Pain · 2024 · 21 citations · Full text

Amifampridine safety and efficacy in spinal muscular atrophy ambulatory patients: a randomized, placebo-controlled, crossover phase 2 trial

Silvia Bonanno, Riccardo Giossi, Riccardo Zanin et al. · Journal of Neurology · 2022 · 12 citations · Full text

, , +6

Systematic Review and Meta-analysis Seem to Indicate that Cannabinoids for Chronic Primary Pain Treatment Have Limited Benefit

Riccardo Giossi, Federica Carrara, Matteo Padroni et al. · Pain and Therapy · 2022 · 11 citations · Full text

Rows per page

1–4 of 4